Phenylephrine Injection Recall Due to Sterility Assurance Concerns
Edge Pharma is recalling phenylephrine injection (20 mg/250 mL) because the manufacturer cannot assure the product maintains sterility. The recall affects 3,930 bags distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall of a sterile injectable pharmaceutical product. Lack of sterility assurance in intravenous medications poses significant risk of serious infection and hospitalization, meeting the Severe criterion for Class II recalls with potential for serious harm.
Plain-English summary
Edge Pharma, LLC is recalling PHENYLephrine, 0.9% Sodium Chloride Injection, USP, 20 mg/250 mL (0.08 mg/mL) in single-use bags for intravenous injection. The product is preservative-free and intended for prescription use.
The recall was initiated because the manufacturer cannot provide assurance that the product maintains sterility. Approximately 3,930 bags have been distributed nationwide with lot codes 08-2021-24@6 (12/06/2021), 08-2021-31@7 (12/12/2021), 09-2021-07@3 (12/21/2021), 10-2021-20@2 (02/02/2022), and 10-2021-28@2 (02/10/2022).
Healthcare providers and patients who have received or are holding this product should discontinue use and contact Edge Pharma, LLC at 856 Hercules Drive, Colchester, VT, for further instructions. Phenylephrine is used as a vasopressor to raise blood pressure; use of a non-sterile formulation poses a serious infection risk in intravenous administration.
The recalled product
- Product
- PHENYLephrine, 0.9% Sodium Chloride Injection, USP, 20 mg/250mL, (0.08 mg/mL), Single use bag for IV injection (Preservative Free), Rx Only, Edge Pharma, LLC, 856 Hercules Dr, Colchester, VT NDC 05446-1667-01
- Manufacturer
- Edge Pharma, LLC
- Category
- Drug — Injectable / Vasopressor
- Affected units
- 3,930
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- 08-2021-24@6 12/06/2021
- 08-2021-31@7 12/12/2021
- 09-2021-07@3 12/21/2021
- 10-2021-20@2 02/02/2022 & 10-2021-28@2 02/10/2022.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 56 recalled by Edge Pharma, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 56 products in this recall →Related recalls
Same manufacturer · Edge Pharma, LLC
See all →- ModerateProfound-PE Dental Gel Recalled for Manufacturing Deviations
FDA (Drugs) · 2022-02-02
- SevereMVASI Sterile Ophthalmic Solution Lacks Assured Sterility
FDA (Drugs) · 2022-02-02
- ModerateLET Topical Gel drug recall for CGMP deviations
FDA (Drugs) · 2022-02-02
- SevereVancomycin HCl Injection Recalled for Sterility Assurance Issues
FDA (Drugs) · 2022-02-02
- ModerateCSF-HC Otic Powder Drug Recalled for Manufacturing Deviations
FDA (Drugs) · 2022-02-02
Same hazard · sterility assurance
See all →- HighArrowhead DE LLC Recalls Arrow-LOK Implants Due to Sterility Assurance Concerns
FDA (Devices) · 2026-08-26
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15
- SevereChloraPrep One-Step Applicators Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2026-07-08
- SevereArrow drainage and thoracentesis kits contain recalled supplier drugs
FDA (Devices) · 2026-06-24